English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Engagement of health care professionals represents an important factor for successful implementation of new practices. To support these professionals’ involvement, it is essential to understand their perspective. This study describes the perspective of professionals in the field of opioid use disorder (OUD), in the province of Quebec (Canada), regarding appropriateness of iOAT for their patients and the obstacles to its implementation. A web-based survey was conducted, with 132 OUD professionals (physicians, pharmacists, nurses and counselors). 80.3% of respondents report prior knowledge of iOAT, 87.6% are interested in obtaining additional information on iOAT, and 98.1% consider iOAT to be very or partially appropriate for their clientele. In terms of barriers to iOAT implementation, the main obstacles highlighted by respondents pertain to the lack of available or qualified staff, access to appropriate facilities and equipment, and patient transportation. Professionals who perceive iOAT to be very appropriate for their clientele are more likely to report a higher number of patients with biopsychosocial deterioration, to consider themselves to be very familiar with iOAT, and to work in a higher population density area. Results highlight feasibility challenges, but support perceived appropriateness of iOAT in a sample of OUD professionals in Quebec.

Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders